NCT07529119 Effect of Consuming a Mango and Chia-based Beverage on Modulating the Intestinal Microbiota in Obese Children
| NCT ID | NCT07529119 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad Nacional de Caaguazu |
| Condition | Microbiota |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-02-09 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-02-09 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized clinical trial evaluates the effect of a mango and chia-based beverage on gut microbiota modulation in 100 Paraguayan children aged 8-16 years with obesity. Participants will consume the intervention beverage for 6 weeks. Fecal samples will be collected before and after each intervention to analyze microbiota composition using 16S rRNA sequencing. This study aims to characterize the gut microbiota of Paraguayan children for the first time and assess whether this functional beverage can positively modulate intestinal bacteria as a potential strategy to address childhood obesity, which affects 1 in 3 school-age children in Paraguay.
Eligibility Criteria
Inclusion Criteria: 100 children aged 8-16 years from Paraguay, stratified by BMI (with/without excess weight). Exclusion Criteria: Allergyc to mango or chia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07529119 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 16 Years, studying Microbiota. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07529119 currently recruiting?
Yes, NCT07529119 is actively recruiting participants. Contact the research team at julietamendez@unca.edu.py for enrollment information.
Where is the NCT07529119 trial being conducted?
This trial is being conducted at Coronel Oviedo, Paraguay.
Who is sponsoring the NCT07529119 clinical trial?
NCT07529119 is sponsored by Universidad Nacional de Caaguazu. The trial plans to enroll 100 participants.